{"api":"v1","generated_at":"2026-10-03T23:07:14.381Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-icc-sm-abdbcc","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-icc-sm-abdbcc/at/2026-10-03T21-12Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-03T21:12:52.186Z","snapshot_stamp":"2026-10-03T21-12Z","endpoint":{"slug":"api-magentlab-com-api-calc-icc-sm-abdbcc","canonical_url":"https://api.magentlab.com/api/calc/icc_sm","resource":"https://api.magentlab.com/api/calc/icc_sm","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"ICC 2022 systemic mastocytosis (Arber 2022). Met when major infiltrates (≥15 tryptase- and/or CD117-positive MCs in aggregates in BM or extracutaneous organ) alone, or ≥3 minors. Minors: >25% spindle or atypical immature morphology, KIT D816V or other activating KIT mutation, CD25/CD2/CD30, tryptase >20 ng/mL (not counted in SM-AMN). Not a diagnosis. Not Valent 2016 WHO SM. Not WHO 5th/Khoury. Not cutaneous mastocytosis only. magent does not read a biopsy or assay tryptase.","service_name":"magent","declared_category":null,"declared_tags":["icc-2022","mastocytosis","hematology","kit","calculator"],"route_template":null,"registry_updated":"2026-09-28T15:11:05.311Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc icc sm","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-03T21:12:52.185Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-03T21:12:52.186Z","calls_30d":1,"unique_payers_30d":1,"last_called_at":"2026-09-28T15:11:05.186Z"},"validation":{"latest":{"observed_at":"2026-10-03T06:59:02.990Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-03"},"uptime":[{"days":7,"observed":7,"passed":7,"ratio":1},{"days":30,"observed":7,"passed":7,"ratio":1},{"days":90,"observed":7,"passed":7,"ratio":1}],"history_90d":[{"observed_at":"2026-10-03T06:59:02.990Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-03","state_changed":false},{"observed_at":"2026-10-02T16:08:50.431Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-02","state_changed":false},{"observed_at":"2026-10-01T08:55:12.601Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T08:20:03.644Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T20:29:08.541Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T17:37:56.158Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:46:51.562Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["icc-2022","mastocytosis","hematology","kit","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/icc_sm","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T15:11:05.186Z","l30DaysTotalCalls":1,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/icc_sm","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"kit_activating":false,"tryptase_gt_20":false,"cd2_cd25_or_cd30":false,"major_infiltrates":true,"atypical_or_spindle":false,"associated_myeloid_neoplasm":false},{"kit_activating":false,"tryptase_gt_20":false,"cd2_cd25_or_cd30":false,"major_infiltrates":true,"atypical_or_spindle":false,"associated_myeloid_neoplasm":false}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/icc_sm","count":2,"items":[{"major":true,"formula":"icc_sm","citation":{"id":"arber-2022","doi":"10.1182/blood.2022015850","pmid":"35767897","title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","source":"Blood. 2022;140(11):1200-1228","authors":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, Wang SA, Bagg A, Barbui T, Bennett JM, de la Fuente J, et al."},"criteria":[{"met":true,"factor":"major"},{"met":false,"factor":"atypical_or_spindle"},{"met":false,"factor":"kit_activating"},{"met":false,"factor":"cd2_cd25_or_cd30"},{"met":false,"factor":"tryptase_counts"},{"met":false,"factor":"associated_myeloid_neoplasm"},{"met":false,"factor":"minor_count_ge_3"}],"diagnosed":true,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","minor_count":0,"kit_activating":false,"tryptase_gt_20":false,"tryptase_counts":false,"cd2_cd25_or_cd30":false,"major_infiltrates":true,"formula_expression":"diagnosed iff major_infiltrates or minor_count ≥ 3; minor_count counts atypical_or_spindle, kit_activating, cd2_cd25_or_cd30, and tryptase_gt_20 only when associated_myeloid_neoplasm is false (Arber 2022 ICC SM). Not a diagnosis. Not Valent 2016 WHO SM. Not cutaneous mastocytosis only","atypical_or_spindle":false,"associated_myeloid_neoplasm":false},{"major":true,"formula":"icc_sm","citation":{"id":"arber-2022","doi":"10.1182/blood.2022015850","pmid":"35767897","title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","source":"Blood. 2022;140(11):1200-1228","authors":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, Wang SA, Bagg A, Barbui T, Bennett JM, de la Fuente J, et al."},"criteria":[{"met":true,"factor":"major"},{"met":false,"factor":"atypical_or_spindle"},{"met":false,"factor":"kit_activating"},{"met":false,"factor":"cd2_cd25_or_cd30"},{"met":false,"factor":"tryptase_counts"},{"met":false,"factor":"associated_myeloid_neoplasm"},{"met":false,"factor":"minor_count_ge_3"}],"diagnosed":true,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","minor_count":0,"kit_activating":false,"tryptase_gt_20":false,"tryptase_counts":false,"cd2_cd25_or_cd30":false,"major_infiltrates":true,"formula_expression":"diagnosed iff major_infiltrates or minor_count ≥ 3; minor_count counts atypical_or_spindle, kit_activating, cd2_cd25_or_cd30, and tryptase_gt_20 only when associated_myeloid_neoplasm is false (Arber 2022 ICC SM). Not a diagnosis. Not Valent 2016 WHO SM. Not cutaneous mastocytosis only","atypical_or_spindle":false,"associated_myeloid_neoplasm":false}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["major_infiltrates","atypical_or_spindle","kit_activating","cd2_cd25_or_cd30","tryptase_gt_20","associated_myeloid_neoplasm"],"properties":{"kit_activating":{"type":"boolean","description":"KIT D816V or other activating KIT mutation in bone marrow, blood, or an extracutaneous organ, as assigned by the caller (Arber 2022 ICC SM minor; not codon-816-only). true or false. magent does not sequence KIT."},"tryptase_gt_20":{"type":"boolean","description":"Serum tryptase persistently >20 ng/mL as assigned by the caller (Arber 2022 ICC SM minor). Does not count when associated_myeloid_neoplasm is true (SM-AMN). true or false. magent does not assay tryptase."},"cd2_cd25_or_cd30":{"type":"boolean","description":"Mast cells express CD25, CD2, and/or CD30 in addition to mast-cell markers, as assigned by the caller (Arber 2022 ICC SM minor; ICC adds CD30). true or false. magent does not phenotype mast cells."},"major_infiltrates":{"type":"boolean","description":"Multifocal dense infiltrates of tryptase- and/or CD117-positive mast cells (≥15 MCs in aggregates) in bone marrow or another extracutaneous organ, as assigned by the caller (Arber 2022 ICC SM major). true or false. magent does not read a biopsy."},"atypical_or_spindle":{"type":"boolean","description":">25% spindle-shaped or atypical immature morphology in bone marrow or extracutaneous sections, as assigned by the caller (Arber 2022 ICC SM minor). true or false. magent does not read slides."},"associated_myeloid_neoplasm":{"type":"boolean","description":"Associated myeloid neoplasm (ICC SM-AMN) as assigned by the caller. When true, tryptase_gt_20 does not count as a minor. true or false. magent does not diagnose a myeloid neoplasm."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"ICC 2022 systemic mastocytosis (Arber 2022). Met when major infiltrates (≥15 tryptase- and/or CD117-positive MCs in aggregates in BM or extracutaneous organ) alone, or ≥3 minors. Minors: >25% spindle or atypical immature morphology, KIT D816V or other activating KIT mutation, CD25/CD2/CD30, tryptase >20 ng/mL (not counted in SM-AMN). Not a diagnosis. Not Valent 2016 WHO SM. Not WHO 5th/Khoury. Not cutaneous mastocytosis only. magent does not read a biopsy or assay tryptase.","lastUpdated":"2026-09-28T15:11:05.311Z","serviceName":"magent","x402Version":2}]}}